US | Recovery Tracker sees strong end to summer
The US Recovery Tracker exited the summer on a bright note. It rose 0.7ppts to 96.7 during the two weeks ended September 3 – the highest reading since late July. Despite downside risks from the Delta variant, the health situation is stabilizing, mobility is nearing its pre-pandemic level, and household spending is steady.
What you will learn:
- Record equity valuations continue to underpin looser financial conditions, but Covid-related supply constraints are limiting production. Employment took a breather on weaker small business payrolls and increased UI benefits searches.
- Regional recoveries stabilized in early September. The South posted its first gain since early July as Delta variant infections fell from their peak.
- New Covid cases remain elevated, but hospitalizations are declining and inoculations are steady at 900k/day. We expect the wider adoption of vaccine mandates following full FDA approval of the Pfizer vaccine will support increasing uptake.
Tags:
Related Services
Post
UK: Supply constraints are probably less prominent in the south
The extent to which UK employers can respond to likely 2024 interest rate cuts with increased output, rather than rises in prices and wages, will partly reflect the extent of spare capacity. This will inevitably vary by region. Evidence on this is imperfect, but in terms of capital assets (including intangibles) and labour availability, southern regions appear to be in a stronger position than those in the UK's traditional industrial heartland.
Find Out More
Post
Global Private equity real estate fund maturities spur asset sales
We expect the significant increases in fund maturities, spurred by capital raised over the past decade, to exert upward pressure on the rate of asset disposals as the funds approach the end of their lifecycles.
Find Out More